Clinical Trial Update: Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of levetiracetam for cramps, spasticity and neuroprotection in motor neuron disease completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Lateral Sclerosis
• Progressive Muscular Atrophy

Drugs mentioned

• LEVETIRACETAM (levetiracetam)

Snippet

Sponsor: Duke University | Conditions: Motor Neuron Disease, Amyotrophic Lateral Sclerosis | Phase 2 | Status: COMPLETED